# US 2010/0166847 A1 · Method for coating fine particles with lipid membrane

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166847 A1
- Document ID: US20100166847A1
- Status: Published application
- Kind: A1
- Application number: 12/656,487
- Filed: 2010-02-01
- Published: 2010-07-01
- Earliest claimed: 2000-10-04
- Assignees: Kyowa Hakko Kirin Co., Ltd.
- Inventors: Yasuki Kato; Masahiro Yamauchi; Hiroko Kusano; Takeshi Iwata; Takaaki Uochi; Shiro Akinaga
- Web page: https://patentgrep.com/patent/US20100166847A1

## CPC

- A61K 9/5123: {Organic compounds, e.g. fats, sugars}
- A61K 9/127: Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K 9/1271: Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers (liposomes as conjugates {A61K47/6911})
- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K 9/141: {Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers ((co) spray-dried products A61K9/16, (co) lyophilised products A61K9/19; the carrier being chemically bound to the active ingredient A61K47/50)}
- A61K 9/146: {with organic macromolecular compounds}
- A61K 9/5015: {Organic compounds, e.g. fats, sugars}
- A61K 9/5192: {Processes}
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61K 47/6911: {the form being a liposome}
- B01J 13/12: removing solvent from the wall-forming material solution
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

An object of the present invention is to provide a safe, convenient and efficient method for coating fine particles with lipid membrane. There is provided a method for coating fine particles with lipid membrane, characterized in that, the rate of a polar organic solvent in an aqueous solution containing the polar organic solvent where the fine particles are dispersed and lipid is dissolved, is decreased.

## Claims

### Claim at position 1

-19. (canceled)

### Claim 20

A coated fine particle comprising:
(i) a complex of a drug selected from a peptide, a protein and a nucleic acid and a liposome,
wherein (a) the drug is selected from an acidic peptide, an acidic protein, and a nucleic acid, the liposome comprises cationic lipid, and the complex is obtained by mixing the drug and the liposome in water, or (b) the drug is selected from a basic peptide and a basic protein, and the liposome comprises anionic lipid, and the complex is obtained by mixing the drug and the liposome in water,
wherein the complex has a diameter of 10 nm to 1,000 nm, and
(ii) closed vesicles of a lipid bilayer formed of lipid(s),
wherein the lipid(s) is selected from phospholipid, glyceroglycolipid, sphingoglycolipid, cholesterol and synthetic lipid,
wherein the complex is coated with the closed vesicles of the lipid bilayer.

### Claim 21 (depends on 20)

The coated fine particle according to claim 20, wherein the complex contains a water-soluble polymer derivative.

### Claim 22 (depends on 20)

The coated fine particle according to claim 20, wherein the liposome comprises a phospholipid and a dextran sulfate sodium salt.

### Claim 23 (depends on 21)

The coated fine particle according to claim 21, wherein the water-soluble polymer derivative is one or more member(s) selected from a polyethylene glycolated lipid, a polyethylene glycol alkyl ether, a polyethylene glycol castor oil derivative, a polyethylene glycol sorbitan fatty acid ester, a polyethylene glycol stearate, a copolymer of ethylene glycol with propylene glycol and a glycerol ester.

### Claim 24 (depends on 20)

The coated fine particle according to claim 20, wherein the lipid(s) is one or more member(s) selected from phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidic acid, phosphatidylglycerol, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, polyethylene glycolated phospholipid, egg yolk lecithin, soybean lecithin and hydrogenated phospholipid.

### Claim 25 (depends on 20)

The coated fine particle according to claim 20, wherein the lipid(s) is a mixture of egg yolk phosphatidylcholine (EggPC) and 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-N-(polyethyleneglycol 2000) (PEG-DSPE).
